By Editor , 3 September 2026

Helsinki – September 03, 2026 -- Helsinki will host two major design events in close succession this year, with Helsinki Design Week running 28 August to 6 September 2026 and Habitare, the Nordic region's leading furniture and interior fair, taking place 2-6 September 2026 at Messukeskus, the Helsinki Expo and Convention Centre.

By Editor , 3 September 2026

Espoo, Finland – September 03, 2026 -- Valmet will supply a flue gas condensing plant to Helen's Salmisaari K6 pellet heating plant in Helsinki, an order booked in Valmet's second-quarter 2026 order intake with commercial start-up scheduled for the second half of 2027.

By Editor , 3 September 2026

HONG KONG – September 03, 2026 -- TCL Electronics Holdings Limited (01070.HK) reported adjusted profit attributable to shareholders of HKD 1.64 billion for the first half of 2026, up 54.3% year-on-year, as revenue climbed 16.4% to HKD 63.76 billion.

Gross profit rose 30.3% to HKD 10.90 billion, while net profit after tax reached HKD 1.62 billion. Annualized return on equity improved 4.2 percentage points to 16.5%. Overall expense ratio was held at 11.7% of revenue, which the company attributed to AI-driven operational efficiency and scale economies.

By Editor , 2 September 2026
Amgen's Repatha Cuts All-Cause Death Risk 20% in Phase 3 Trial

MUNICH, Germany -- August 31, 2026 -- Amgen's Repatha (evolocumab) reduced all-cause mortality by 20% in high-risk patients who had never suffered a heart attack or stroke, according to a pre-specified analysis of the Phase 3 VESALIUS-CV trial presented at the European Society of Cardiology Congress 2026 and published simultaneously in Circulation.

By Editor , 2 September 2026
Phoenix Tower Signs $6.5 Billion Financing Across 23 Countries

BOCA RATON, Fla. -- Aug. 31, 2026 -- Phoenix Tower International (PTI) has signed a $6.5 billion multi-jurisdiction financing package, the largest such deal for a privately held tower company in the wireless infrastructure sector.

By Editor , 2 September 2026
EYKON Rebrands From Landis+Gyr EMEA, Serves 75 Utility Markets

CHAM, Switzerland -- August 31, 2026 -- EYKON officially unveiled its new brand today, completing a separation from Landis+Gyr EMEA and establishing itself as an independent utility infrastructure technology company serving more than 75 markets.

The Swiss-based firm now supports over 100 million connected devices across the EMEA region, drawing on 130 years of utility-sector history rooted in Landis+Gyr's legacy operations.

By Editor , 2 September 2026
SWI Group Joins NVIDIA Cloud Partner Program as Preferred Partner

AMSTERDAM -- September 01, 2026 -- SWI Group, an Amsterdam-listed investment firm with 3.6 gigawatts of electrical capacity across Europe and the United States, announced on August 31, 2026 that it has joined the NVIDIA Cloud Partner (NCP) program as a preferred partner. The designation places SWI Group in a limited circle of NVIDIA partners with validated AI infrastructure skills. Membership gives the firm access to NVIDIA's reference architectures and validated configurations for rolling out NVIDIA-certified compute capacity as its platform expands.

By Editor , 2 September 2026
Half of Temu's European Sellers Add Jobs or Capacity, Survey Shows

Dublin -- CURRENT_DATE -- Half of 152 European merchants surveyed by Temu said they expanded production capacity or hired new staff since joining the e-commerce platform, according to the Temu Small Business Insights Report 2026. The online survey ran in June and July 2026 among sellers in Germany, France, Spain, Italy, Poland and the United Kingdom. One in three respondents said they expanded into new international markets after starting to sell on Temu, which has opened its Local Seller Program to businesses in more than 35 markets since 2024.

By Editor , 2 September 2026
Amgen's Repatha Cuts All-Cause Death Risk 20% in Phase 3 Trial

THOUSAND OAKS, Calif. -- September 01, 2026 -- Amgen said its cholesterol drug Repatha reduced the risk of death by 20% among more than 12,000 high-risk adults who had not yet suffered a heart attack or stroke, based on a pre-specified analysis of the Phase 3 VESALIUS-CV trial. The company presented the data in a late-breaking session at the European Society of Cardiology Congress 2026 in Munich, Germany, and published the findings simultaneously in Circulation.